Assessment of Endoscopic Disease Activity in Ulcerative Colitis: Is Simplicity the Ultimate Sophistication?
Endoscopy
Mayo Endoscopic Score
Mucosal healing
Ulcerative colitis
Journal
Inflammatory intestinal diseases
ISSN: 2296-9365
Titre abrégé: Inflamm Intest Dis
Pays: Switzerland
ID NLM: 101677990
Informations de publication
Date de publication:
Jan 2022
Jan 2022
Historique:
received:
26
03
2021
accepted:
27
06
2021
entrez:
28
2
2022
pubmed:
1
3
2022
medline:
1
3
2022
Statut:
epublish
Résumé
Endoscopic remission is an increasingly recognized important therapeutic endpoint in the management of patients with UC. The Mayo Endoscopic Score (MES) remains the most common endoscopic index recommended in guidelines and widely used in clinical trials and in clinical practice. The MES is easy, simple, and practical but is suboptimal at providing an accurate depiction of segmental healing and/or at measuring a substantial but incomplete response across the spectrum of endoscopic inflammation. Other endoscopic scores have been proposed but have not received wide recognition or adoption.
Sections du résumé
BACKGROUND
BACKGROUND
Endoscopic remission is an increasingly recognized important therapeutic endpoint in the management of patients with UC.
SUMMARY
CONCLUSIONS
The Mayo Endoscopic Score (MES) remains the most common endoscopic index recommended in guidelines and widely used in clinical trials and in clinical practice. The MES is easy, simple, and practical but is suboptimal at providing an accurate depiction of segmental healing and/or at measuring a substantial but incomplete response across the spectrum of endoscopic inflammation. Other endoscopic scores have been proposed but have not received wide recognition or adoption.
Identifiants
pubmed: 35224012
doi: 10.1159/000518131
pii: iid-0007-0007
pmc: PMC8820167
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
7-12Informations de copyright
Copyright © 2021 by S. Karger AG, Basel.
Déclaration de conflit d'intérêts
No conflicts of interest exist.
Références
Am J Gastroenterol. 1999 Nov;94(11):3258-62
pubmed: 10566726
Am J Gastroenterol. 2015 Sep;110(9):1324-38
pubmed: 26303131
N Engl J Med. 2017 May 4;376(18):1723-1736
pubmed: 28467869
Clin Gastroenterol Hepatol. 2017 Oct;15(10):1557-1564.e1
pubmed: 28238954
Gastroenterology. 2021 Feb;160(3):710-719.e2
pubmed: 33098883
J Crohns Colitis. 2015 Oct;9(10):846-52
pubmed: 26116558
Gastroenterology. 2007 Feb;132(2):763-86
pubmed: 17258735
Rev Esp Enferm Dig. 2016 Nov;108(11):697-702
pubmed: 27701881
J Crohns Colitis. 2016 Jan;10(1):13-9
pubmed: 26351390
JAMA Netw Open. 2019 May 3;2(5):e193963
pubmed: 31099869
Gastroenterology. 2012 Feb;142(2):257-65.e1-3
pubmed: 22062358
Gastroenterology. 2020 Apr;158(5):1450-1461
pubmed: 31945371
Clin Gastroenterol Hepatol. 2011 Jun;9(6):483-489.e3
pubmed: 21195796
N Engl J Med. 2013 Aug 22;369(8):699-710
pubmed: 23964932
Gastroenterology. 2014 Jan;146(1):96-109.e1
pubmed: 23770005
J Crohns Colitis. 2016 Mar;10(3):286-95
pubmed: 26581895
Aliment Pharmacol Ther. 2017 May;45(10):1291-1302
pubmed: 28326566
N Engl J Med. 2019 Sep 26;381(13):1201-1214
pubmed: 31553833
N Engl J Med. 2005 Dec 8;353(23):2462-76
pubmed: 16339095
Clin Endosc. 2019 Mar;52(2):129-136
pubmed: 30130840
Gastroenterology. 2021 Apr;160(5):1570-1583
pubmed: 33359090